Spanish Hospital Joins World’s Largest Study of Risk for Familial Pancreatic Cancer
Designed to validate Immunovia’s blood-based test for familial pancreatic cancer risk, the study will analyze more than 1,000 individuals across sites in the United States and Europe.
Read More